Neoadjuvant Sequential Docetaxel Followed by High‐Dose Epirubicin in Combination With Cyclophosphamide Administered Concurrently With Trastuzumab. The DECT Trial

To report the results of the DECT trial, a phase II study of locally advanced or operable HER2‐positive breast cancer (BC) treated with taxanes and concurrent anthracyclines and trastuzumab. Eligible patients (stage IIA‐IIIB HER2‐positive BC, 18–75 years, normal organ functions, ECOG ≤1, and left ve...

全面介紹

Na minha lista:
書目詳細資料
發表在:J Cell Physiol
Main Authors: Pizzuti, Laura, Barba, Maddalena, Giannarelli, Diana, Sergi, Domenico, Botti, Claudio, Marchetti, Paolo, Anzà, Michele, Maugeri‐Saccà, Marcello, Natoli, Clara, Di Filippo, Simona, Catenaro, Teresa, Tomao, Federica, Amodio, Antonella, Carpano, Silvia, Perracchio, Letizia, Mottolese, Marcella, Di Lauro, Luigi, Sanguineti, Giuseppe, Di Benedetto, Anna, Giordano, Antonio, Vici, Patrizia
格式: Artigo
語言:Inglês
出版: John Wiley and Sons Inc. 2016
主題:
Original Research Articles
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC5089631/
https://ncbi.nlm.nih.gov/pubmed/27187274
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jcp.25432
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍